Weight loss drugs could soon be used to treat these seven other health conditions
However, Novo Nordisk has warned that the rise in copycat versions of its weight-loss drug in the U.S. and competition from Lilly across several markets is expected to hurt Wegovy sales this year.
Both companies are actively exploring other medical uses for these GLP-1 drugs, aiming to broaden their market reach and secure wider health insurance coverage, a strategy that has already seen some success.
Here are some of the other conditions the drugs are being used and tested for:
Alcohol addiction
A study conducted by the University of Copenhagen 's Psychiatric Centre Rigshospitalet, is investigating whether semaglutide - the main ingredient in Wegovy and Ozempic - can help reduce alcohol intake in 108 patients diagnosed with alcohol use disorder and obesity.
Alzheimer's disease
Novo Nordisk is testing semaglutide in a late-stage trial in patients with early Alzheimer's disease.
The study, which will enrol 1,840 patients, could have an initial data readout as early as later this year.
Cardiovascular disease
Eli Lilly was testing tirzepatide - the main ingredient in Mounjaro and Zepbound - for patients with heart failure and obesity. Lilly had said it would enrol about 700 people in the study, but the company said in May that it had withdrawn its U.S. application for heart failure approval.
The European Medicines Agency backed the use of Novo's semaglutide to help ease heart failure symptoms in people with obesity in September 2024.
Chronic kidney disease
Novo's Ozempic is approved in the United States for reducing the risk of kidney failure and disease progression, as well as the risk of death due to heart problems in diabetes patients with chronic kidney disease.
Lilly's tirzepatide is being evaluated in a mid-stage study of patients with chronic kidney disease and obesity. Lilly plans to enrol up to 140 participants with the study expected to be completed next year.
Liver disease
Novo is testing semaglutide in a late-stage trial of patients with a common, but difficult to treat, type of fatty liver disease called non-alcoholic steatohepatitis, or NASH. The study is expected to be completed in April 2029 and include about 1,200 patients.
Lilly's tirzepatide helped up to 74 per cent of patients achieve absence of the disease with no worsening of liver scarring at 52 weeks, compared with 13 per cent of patients on placebo, in a mid-stage trial for NASH, which is also now referred to as metabolic dysfunction-associated steatohepatitis, or MASH.
Neurological disorders
Researchers at the Danish Headache Centre are testing semaglutide along with a very low-calorie diet as a treatment for new-onset idiopathic intracranial hypertension, a condition associated with obesity in which blood pressure inside the head rises.
The study has enrolled about 50 patients and is expected to be completed in October 2025.
Sleep apnea
Zepbound was approved by the U.S. Food and Drug Administration for obstructive sleep apnea in December 2024, making it the first drug to directly treat patients with the common disorder that causes breathing disruption while sleeping.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
an hour ago
- Reuters
Sectors Up Close: AI 'could improve drugmaker revenues by 12%'
The healthcare sector has trailed behind other stocks this year, as drugmakers like Ozempic maker Novo Nordisk and Eli Lilly have found themselves in fierce competition with each other over the obesity drug market. Leah Bennett of Concurrent Asset Management told Reuters AI could shrink the cost of clinical trials and bring many more medicines onto the market - leading to a rush of M&A in the biotech sector.
The Independent
an hour ago
- The Independent
Infections linked to wipes which may have been used to clean cuts
Health chiefs have linked a number of infections to certain cleaning wipes and urged people not to use them to treat cuts and scrapes. Certain products should be binned to avoid contamination, officials said. It comes after an outbreak of a bacteria, burkholderia stabilis (B. stabilis). There have been 51 confirmed cases of B. stabilis between 2018 and 2025, with 'some serious infections which have required hospital treatment', the UK Health Security Agency (UKHSA) said. Health chiefs said the outbreak is 'suspected to be associated with some non-sterile alcohol-free wipe products'. UKHSA and the Medicines and Healthcare Products Regulatory Agency (MHRA) are advising people to stop using the products, which they may find in their at-home first aid kit, and to put them in the bin. This includes: ValueAid Alcohol Free Cleansing Wipes; Microsafe Moist Wipe Alcohol Free and Steroplast Sterowipe Alcohol Free Cleansing Wipes. Testing also found contamination of Reliwipe Alcohol Free Cleansing Wipes, though with a different strain of the bacteria linked to the outbreak. While the warning only relates to the wipes listed, officials have reminded the public that non-sterile alcohol-free wipes should not be used for the treatment of wounds. Dr James Elston, consultant in epidemiology at the UKHSA said: 'While the overall risk to the public remains very low, a number of non-sterile alcohol-free wipe products have been linked to an outbreak of Burkholderia stabilis. 'It is important these types of wipes are not used for the treatment of injuries, wounds, or broken skin, and that they are not used to clean intravenous lines. 'When treating cuts and grazes, it is important to follow NHS advice.' Dr Alison Cave, MHRA's chief safety officer, added: 'We consider wipes which are intended for a medical purpose to be medicines. These products do not have a medicines authorisation, and we are taking appropriate action to ensure compliance with the requirements of the applicable legislation governed by MHRA. 'If you have these wipes at home or in a first aid kit, please check the label and only use wipes marked as 'sterile' on broken skin.'
The Independent
an hour ago
- The Independent
Avoiding these simple foods could help people lose twice as much weight, study finds
Cooking from scratch and avoiding ultra-processed foods like pre-packaged sandwiches and protein bars could help people lose twice as much weight, a study has found. Ultra-processed food (UPF) is typically high in saturated fat, salt and sugar, contains ingredients you would not find in your kitchen cupboard like emulsifiers and preservatives, and is ready-to-eat or heat. The study published in the journal Nature compared a UPF diet to a minimally processed one, and found avoiding UPFs helped curb food cravings, increased weight loss and improved fat loss. The trial, led by experts at University College London (UCL) and University College London Hospitals NHS Foundation Trust (UCLH), involved 55 people who were overweight but otherwise healthy. Half of the participants were given an eight-week diet plan comprising minimally processed foods such as overnight oats, cottage pie and chicken salad cooked from scratch. The other half were given a diet of ready-to-eat protein bars, shop-bought sandwiches and microwave lasagne. Both diets were matched nutritionally and contained the recommended levels of fat, saturated fat, protein, carbohydrates, salt and fibre. After completing one diet for eight weeks, the groups switched. Dr Samuel Dicken, of the UCL centre for obesity research and UCL department of behavioural science and health, said: 'Previous research has linked ultra-processed foods with poor health outcomes. 'But not all ultra-processed foods are inherently unhealthy based on their nutritional profile.' Researchers aimed to find out whether eating more processed foods impacts weight, blood pressure, body composition and food cravings. Results showed those on the minimally processed diet lost twice as much weight (2.06 per cent) compared to the UPF diet (1.05 per cent loss). Those on the UPF diet also did not lose as much fat, researchers said. Dr Dicken explained that although a 2 per cent reduction may not seem like much weight loss, it is a significant amount for eight weeks. 'If we scaled these results up over the course of a year, we'd expect to see a 13 per cent weight reduction in men and a 9 per cent reduction in women on the minimally processed diet, but only a 4 per cent weight reduction in men and 5 per cent in women after the ultra-processed diet,' Dr Dicken said. However, researchers measured other markers like blood pressure, heart rate, liver function, glucose levels and cholesterol but found no significant negative impacts of the UPF diet. Gunter Kuhnle, professor of food science and nutrition at Reading University, who was not involved in the study, told The Independent: 'I think it confirms it is not processing that is important but rather food composition.' He suggests consumers should focus more on composition, such as carbohydrates and fats, rather than on processing. However, those on the UPF diet ate more calories than those on the minimally processed diet. The NHS recommends the average woman should consume around 2,000 calories a day, while the average man should consume 2,500. Participants were given more food than they needed, but those on a minimally processed diet spontaneously had 230 calories less than is recommended and those on the UPF diet had 120 calories less. A questionnaire also revealed those on the minimally processed diet had fewer cravings than people on the diet of ready meals and packaged snacks. Rob Hobson, registered nutritionist and author of Unprocess Your Family Life, who was also not involved in the study, told The Independent: 'The findings support the idea that cutting back on UPFs may help with appetite control and weight regulation and not because UPFs are inherently toxic, but because of how they affect eating behaviour. 'Many are designed to be hyper-palatable, easy to eat quickly, and less satisfying. They don't give us the same satiety signals as minimally processed foods.' Professor Rachel Batterham, senior author of the study, said: 'The best advice to people would be to stick as closely to nutritional guidelines as they can by moderating overall energy intake, limiting intake of salt, sugar and saturated fat, and prioritising high-fibre foods such as fruits, vegetables, pulses and nuts. 'Choosing less processed options such as whole foods and cooking from scratch, rather than ultra-processed, packaged foods or ready meals, is likely to offer additional benefits in terms of body weight, body composition and overall health.'
